Clinical trial
Korean Post-marketing Surveillance for Onglyza®
NCT01575483 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Korean Post-marketing Surveillance for Onglyza®
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2012
- Completion date
- September 7, 2016
- Enrollment
- 3,433 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.